RDSMY - Koninklijke DSM N.V.

Other OTC - Other OTC Delayed Price. Currency in USD
31.02
-0.14 (-0.45%)
At close: 3:54PM EST
Stock chart is not supported by your current browser
Previous Close31.16
Open30.96
Bid0.00 x 0
Ask0.00 x 0
Day's Range30.92 - 31.20
52 Week Range25.55 - 32.87
Volume568,273
Avg. Volume110,113
Market Cap21.896B
Beta (5Y Monthly)1.22
PE Ratio (TTM)19.00
EPS (TTM)1.63
Earnings DateN/A
Forward Dividend & Yield0.43 (1.37%)
Ex-Dividend DateAug 15, 2019
1y Target Est33.00
  • PR Newswire

    DSM - Repurchase of Shares (10-14 February 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 238,303 of its own shares in the period from 10 February 2020 up to and including 14 February 2020 at an average price of €116.31. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €27.7 million.

  • Moody's

    Departement de la Seine Maritime -- Moody's announces completion of a periodic review of ratings of Seine Maritime, Department of

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Seine Maritime, Department of and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • PR Newswire

    DSM - Repurchase of Shares (3-7 February 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 80,423 of its own shares in the period from 3 February 2020 up to and including 7 February 2020 at an average price of €113.07. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €9.1 million.

  • PR Newswire

    DSM - Repurchase of Shares (27-31 January 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 195,502 of its own shares in the period from 27 January 2020 up to and including 31 January 2020 at an average price of €110.38. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €21.6 million.

  • Is Koninklijke DSM N.V.'s (AMS:DSM) CEO Salary Justified?
    Simply Wall St.

    Is Koninklijke DSM N.V.'s (AMS:DSM) CEO Salary Justified?

    In 2007 Feike Sijbesma was appointed CEO of Koninklijke DSM N.V. (AMS:DSM). This analysis aims first to contrast CEO...

  • PR Newswire

    DSM - Repurchase of Shares (20-24 January 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 110,420 of its own shares in the period from 20 January 2020 up to and including 24 January 2020 at an average price of €111.85. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €12.4 million.

  • PR Newswire

    DSM - Repurchase of Shares (13-17 January 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 213,886 of its own shares in the period from 13 January 2020 up to and including 17 January 2020 at an average price of €109.84. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €23.5 million.

  • PR Newswire

    DSM Names Feike Sijbesma Honorary Chairman

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces CEO Feike Sijbesma will be appointed as Honorary Chairman of the company. In this role, Feike Sijbesma will continue to act as an ambassador to DSM.

  • PR Newswire

    DSM - Repurchase of Shares (6-10 January 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 225,888 of its own shares in the period from 6 January 2020 up to and including 10 January 2020 at an average price of €114.73. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €25.9 million.

  • The Koninklijke DSM (AMS:DSM) Share Price Is Up 150% And Shareholders Are Boasting About It
    Simply Wall St.

    The Koninklijke DSM (AMS:DSM) Share Price Is Up 150% And Shareholders Are Boasting About It

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

  • PR Newswire

    DSM - Repurchase of Shares (2-3 January 2020)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 28,011 of its own shares in the period from 2 January 2020 up to and including 3 January 2020 at an average price of €116.83. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €3.3 million.

  • PR Newswire

    Royal DSM Completes Acquisition of Royal CSK

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the completion of the acquisition of a 100% interest in specialty dairy solutions provider Koninklijke CSK Food Enrichment C.V. ("CSK") for a cash consideration of about €150 million. The acquisition of CSK was first announced on November 18.

  • PR Newswire

    DSM - Repurchase of Shares (16-20 December 2019)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 308,286 of its own shares in the period from 16 December 2019 up to and including 20 December 2019 at an average price of €115.95. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €35.7 million.

  • PR Newswire

    DSM - Repurchase of Shares (9-13 December 2019)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 347,955 of its own shares in the period from 9 December 2019 up to and including 13 December 2019 at an average price of €114.42. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €39.8 million.

  • Moody's

    Departement de la Seine Maritime -- Moody's assigns A1/Prime-1 issuer ratings to the Département de la Seine Maritime; positive outlook

    Moody's Public Sector Europe ("Moody's") has today assigned an A1 long-term issuer rating and a Prime-1 short-term issuer rating to the Département de la Seine Maritime (DSM). "The Département de la Seine Maritime's A1/ Prime-1 issuer ratings reflect a strong operating performance, a secure liquidity profile and a commitment to preserve the département's financial health, exemplified by good financial and management practices," says Cédric Poynard, Analyst in Moody's Sub-Sovereign Group and lead analyst for DSM. After dealing with the steady decline of central government transfers, the département benefits from the 2018 binding agreement that will stabilize central government transfers until 2020.

  • Don't Sell Koninklijke DSM N.V. (AMS:DSM) Before You Read This
    Simply Wall St.

    Don't Sell Koninklijke DSM N.V. (AMS:DSM) Before You Read This

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...

  • PR Newswire

    DSM - Repurchase of Shares (2 - 6 December 2019)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 438,649 of its own shares in the period from 2 December 2019 up to and including 6 December 2019 at an average price of €114.60. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €50.3 million.

  • PR Newswire

    Update on DSM Supervisory Board Composition

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces that for the Annual General Meeting of Shareholders to be held on 8 May 2020, the DSM Supervisory Board will nominate Mr. Thomas Leysen for appointment as a new Supervisory Board member. It also announces which Supervisory Board members will be nominated for reappointment.

  • PR Newswire

    DSM - Repurchase of shares (25 - 29 November 2019)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 284,636 of its own shares in the period from 25 November 2019 up to and including 29 November 2019 at an average price of €117.00. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €33.3 million.

  • PR Newswire

    Royal DSM Announces CEO Succession

    The Supervisory Board of Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces the upcoming succession of CEO Feike Sijbesma, who will hand over his responsibilities to his Managing Board colleagues Geraldine Matchett and Dimitri de Vreeze as Co-CEO's in February 2020 and will support a smooth transition until May 2020.

  • PR Newswire

    DSM - Repurchase of Shares (18 - 22 November 2019)

    Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 445,046 of its own shares in the period from 18 November 2019 up to and including 22 November 2019 at an average price of €116.60. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €51.9 million.

  • PR Newswire

    DSM - Repurchase of Shares (11 - 15 November 2019)

    HEERLEN, Netherlands , Nov. 19, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 428,180 of its own shares in the period from ...

  • PR Newswire

    Royal DSM to Acquire Royal CSK, Combining Complementary Strengths to Better Serve Global Dairy Industries

    HEERLEN, Netherlands, Nov. 18, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces that it has reached agreement with the shareholders of specialty dairy solutions provider Koninklijke CSK Food Enrichment C.V. ("CSK") for the acquisition of a 100% interest in the company for a cash consideration of about €150 million. Dairy is DSM's single largest segment in food and beverages, and customers are increasingly looking for solution providers with a broad portfolio of offerings and deep expertise, to support them in delivering differentiating, delicious and sustainable end products to consumers. The combination of DSM's dairy business and CSK will be even better able to serve those needs, and well-placed to address the fast-growing and attractive dairy cultures markets.

  • A Look At The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
    Simply Wall St.

    A Look At The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)

    How far off is Koninklijke DSM N.V. (AMS:DSM) from its intrinsic value? Using the most recent financial data, we'll...

  • PR Newswire

    Cargill-DSM Joint Venture Avansya Starts Commercial-scale Production of EverSweet™ Stevia Sweetener, as Consumers Increasingly Demand Reduced-calorie Food and Beverages

    HEERLEN, Netherlands and WAYZATA, Minnesota, Nov. 14, 2019 /PRNewswire/ -- As consumers continue to watch their calorie intake and strive to live a healthier lifestyle, food and beverage manufacturers are in need of great-tasting, zero-calorie sweeteners to help them achieve these goals. To meet this demand, Avansya, the joint venture between Cargill and Royal DSM, has today started production at the first commercial-scale fermentation facility for stevia sweeteners in the U.S. The facility is producing EverSweet™, a non-artificial, zero-calorie stevia sweetener.